Aurora Cannabis Inc. vs Pfizer, Inc. — Stock Comparison

ACB
Aurora Cannabis Inc.
$3.48
▲ 1.16%
vs
PFE
Pfizer, Inc.
$26.33
▼ 1.39%
Q·Score Winner
Pfizer, Inc.
PFE6.5/10vs 4.8/10

Q·Score Breakdown

4.8
Bearish
Overall
6.5
Neutral
2.2
Quality
7.4
8.2
Health
7
2.4
Growth
5.6
6.3
Valuation
6.7
5.6
Sentiment
5.2
ACB

Clean balance sheet with low leverage (0.2× debt-to-equity).

currently unprofitable (-23% margin).

PFE

Strong profitability with 12% net profit margins.

analyst sentiment is cautious.

Analyst Consensus

BUY
Target $6.42 (+84.5%)
1 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts

Fundamentals

ACB
PFE
Trailing P/E
19.4×
-31.6×
Forward P/E
9.4×
-22.5%
Profit Margin
12.4%
36.0%
Gross Margin
75.8%
-15.5%
ROE
8.9%
6.8%
Revenue Growth
-1.2%
-94.7%
Earnings Growth
1.32
Beta
0.39
Price / Book
$206M
Market Cap
$149.8B
$3 – $7
52-Week Range
$22 – $29

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →